Thermo Fisher Scientific announces the availability of a direct-from-saliva PCR test for COVID-19 to help enable widespread, high-frequency surveillance testing. The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and is designed to simplify lab workflows using widely available instruments and quickly deliver reliable data. By performing the test directly from raw saliva and eliminating the need for equipment, materials, time, and labor associated with nucleic acid extraction, the TaqCheck SARS-CoV-2 Fast PCR Assay helps labs meet CDC turnaround time recommendations.

• Thermo Fisher Scientific